Clinical Trial Update: Radiation and Androgen Ablation for Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating the combination of radiation therapy with androgen deprivation for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Prostate

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• Radiation therapy

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Adenocarcinoma of the Prostate | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-02-11